Wide-Moat Stocks: Companies Dominating Their Markets
Warren Buffett popularized the concept of an economic moat — a durable competitive advantage that protects a company’s profits and market share from rivals over time, much like the water surrounding a medieval castle protected its inhabitants. Morningstar later formalized the idea into a three-tier rating system: wide moat (advantages expected to last 20+ years), narrow moat (at least 10 years), and no moat.
Morningstar identifies five sources from which a moat can be derived:
- Network effect: The product becomes more valuable as more people use it — Visa, Mastercard, and Meta are classic examples.
- Intangible assets: Patents, brands, and regulatory licenses that block competitors — Coca-Cola’s brand power and Moody’s regulatory standing fall here.
- Switching costs: Customers face high costs or friction when changing providers — Microsoft’s enterprise software suite is a textbook case.
- Cost advantage: Structural cost efficiencies that competitors cannot replicate — Waste Management’s vertically integrated network of landfills, recycling centers, and exclusive municipal licenses is nearly impossible for new entrants to match.
- Efficient scale: Markets that naturally support only one or a few players — Union Pacific in railroads and ASML in extreme ultraviolet lithography, where it holds a near-monopoly on EUV systems essential for producing the most advanced semiconductor chips.
Wide-moat companies cluster heavily in technology, healthcare, consumer staples, financials, and industrials. Six of the Magnificent Seven — Nvidia, Meta Platforms, Apple, Amazon, Microsoft, and Alphabet — carry wide-moat designations. Beyond tech, names like LVMH, Novo Nordisk, and Ferrari maintain advantages rooted in heritage, patents, and exclusivity that competitors simply cannot replicate.
For those interested in a fund-based approach, the VanEck Morningstar Wide Moat ETF (MOAT) tracks the Morningstar Wide Moat Focus Index, which selects attractively priced companies with wide-moat ratings and rebalances quarterly across two staggered sub-portfolios of 40 stocks each.
Regulated brokerThe table below lists companies with unrivalled economic moats — businesses with dominant, hard-to-replicate market positions. All data including price and market cap are updated regularly.
| Stock | Price | Change % | Marketcap |
|---|---|---|---|
Gilead Sciences GILD | $133.48 | 0.56% | 165.68B |
Boeing BA | $224.38 | 1.39% | 176.88B |
| $61.04 | 0.07% | 27.77B | |
Walt Disney DIS | $100.48 | 0.82% | 178.00B |
Corteva CTVA | $83.90 | 2.71% | 56.33B |
| $56.95 | 0.75% | 116.30B | |
| $384.27 | 1.22% | 4.66T | |
Veeva Systems VEEV | $171.19 | 0.57% | 28.14B |
| $72.79 | 0.84% | 121.55B | |
TransUnion TRU | $68.24 | 1.17% | 13.16B |
U.S. Bancorp USB | $55.60 | 0.65% | 86.46B |
| $117.53 | 4.77% | 33.21B | |
| $292.35 | 0.55% | 73.81B | |
Allegion ALLE | $132.29 | 0.15% | 11.37B |
Kenvue KVUE | $17.37 | 1.28% | 33.35B |
| $83.01 | 0.41% | 16.06B | |
Pfizer PFE | $26.45 | 0.57% | 150.46B |
| $257.12 | 0.29% | 6.88B | |
Nike NKE | $43.06 | 0.07% | 63.77B |
| $70.77 | 0.97% | 18.08B | |
| $98.07 | 1.83% | 83.33B | |
Teradyne TER | $357.10 | 5.83% | 55.90B |
| $82.85 | 1.87% | 29.97B | |
| $20.91 | 2.00% | 6.23B | |
Adobe ADBE | $255.62 | 0.64% | 103.32B |
| $98.48 | 3.36% | 53.29B | |
MarketAxess MKTX | $151.29 | 2.32% | 5.32B |
| $326.13 | 10.25% | 12.84B | |
Brown Forman Inc BF-B | $26.26 | 6.49% | 12.05B |
Salesforce CRM | $186.99 | 0.81% | 152.97B |
Charles Schwab SCHW | $92.40 | 1.01% | 161.90B |
Emerson EMR | $138.38 | 2.16% | 77.77B |
Amazon AMZN | $273.55 | 0.54% | 2.94T |
| $1,588.12 | 0.94% | 78.02B | |
Autodesk ADSK | $249.43 | 0.76% | 52.63B |
| $303.93 | 1.87% | 67.68B | |
Amgen AMGN | $329.59 | 1.77% | 177.98B |
Otis Worldwide OTIS | $75.62 | 0.34% | 29.02B |
| $466.76 | 0.90% | 173.46B | |
Lam Research LRCX | $275.80 | 6.66% | 344.91B |
Masco MAS | $70.41 | 2.80% | 14.20B |
Mondelez MDLZ | $61.36 | 0.03% | 78.76B |
Honeywell HON | $209.06 | 0.25% | 132.47B |
| $558.60 | 1.48% | 79.34B | |
Equifax EFX | $170.02 | 1.29% | 20.51B |
IDEX IEX | $215.76 | 0.67% | 15.97B |
Microsoft MSFT | $411.38 | 0.54% | 3.06T |
Danaher DHR | $174.63 | 0.34% | 123.60B |
Merck MRK | $113.15 | 0.04% | 279.47B |
| $149.80 | 1.12% | 25.80B | |
| $309.97 | 3.26% | 21.90B | |
Apple AAPL | $284.18 | 2.64% | 4.17T |
